BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38254922)

  • 1. A Novel Homozygous Loss-of-Function Variant in
    Onore ME; Caiazza M; Farina A; Scarano G; Budillon A; Borrelli RN; Limongelli G; Nigro V; Piluso G
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal recessive Noonan-like syndrome caused by homozygosity for a previously unreported variant in SPRED2.
    Markholt S; Andreasen L; Bjerre J; Gregersen PA; Andersen BN
    Eur J Med Genet; 2023 Feb; 66(2):104695. PubMed ID: 36608738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.
    Yaoita M; Niihori T; Mizuno S; Okamoto N; Hayashi S; Watanabe A; Yokozawa M; Suzumura H; Nakahara A; Nakano Y; Hokosaki T; Ohmori A; Sawada H; Migita O; Mima A; Lapunzina P; Santos-Simarro F; García-Miñaúr S; Ogata T; Kawame H; Kurosawa K; Ohashi H; Inoue S; Matsubara Y; Kure S; Aoki Y
    Hum Genet; 2016 Feb; 135(2):209-22. PubMed ID: 26714497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPRED2 loss-of-function causes a recessive Noonan syndrome-like phenotype.
    Motta M; Fasano G; Gredy S; Brinkmann J; Bonnard AA; Simsek-Kiper PO; Gulec EY; Essaddam L; Utine GE; Guarnetti Prandi I; Venditti M; Pantaleoni F; Radio FC; Ciolfi A; Petrini S; Consoli F; Vignal C; Hepbasli D; Ullrich M; de Boer E; Vissers LELM; Gritli S; Rossi C; De Luca A; Ben Becher S; Gelb BD; Dallapiccola B; Lauri A; Chillemi G; Schuh K; Cavé H; Zenker M; Tartaglia M
    Am J Hum Genet; 2021 Nov; 108(11):2112-2129. PubMed ID: 34626534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and clinical profile of patients referred as Noonan or Noonan-like syndrome in Greece: a cohort of 86 patients.
    Papadopoulos G; Papadopoulou A; Kosma K; Papadimitriou A; Papaevangelou V; Kanaka-Gantenbein C; Bountouvi E; Kitsiou-Tzeli S
    Eur J Pediatr; 2022 Oct; 181(10):3691-3700. PubMed ID: 35904599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of hotspot mutation in PTPN11 gene among Moroccan patients with Noonan syndrome.
    Ouboukss F; Adadi N; Amasdl S; Smaili W; Laarabi FZ; Lyahyai J; Sefiani A; Ratbi I
    J Appl Genet; 2024 May; 65(2):303-308. PubMed ID: 37987971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in Noonan syndrome.
    Pierpont ME; Digilio MC
    Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
    Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
    Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1, RAF1, RIT1 variants, and large deletion in NF1.
    Uludağ Alkaya D; Lissewski C; Yeşil G; Zenker M; Tüysüz B
    Am J Med Genet A; 2021 Dec; 185(12):3623-3633. PubMed ID: 34184824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: clinical and molecular findings in 11 patients].
    Carcavilla A; García-Miñaúr S; Pérez-Aytés A; Vendrell T; Pinto I; Guillén-Navarro E; González-Meneses A; Aoki Y; Grinberg D; Ezquieta B
    Med Clin (Barc); 2015 Jan; 144(2):67-72. PubMed ID: 25194980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel RAF1 mutation p.(Gly361Ala) located outside the kinase domain of the CR3 region in two patients with Noonan syndrome, including one with a rare brain tumor.
    Harms FL; Alawi M; Amor DJ; Tan TY; Cuturilo G; Lissewski C; Brinkmann J; Schanze D; Kutsche K; Zenker M
    Am J Med Genet A; 2018 Feb; 176(2):470-476. PubMed ID: 29271604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
    Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
    Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort.
    Chen H; Li X; Liu X; Wang J; Zhang Z; Wu J; Huang M; Guo Y; Li F; Wang X; Fu L
    Orphanet J Rare Dis; 2019 Feb; 14(1):29. PubMed ID: 30732632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noonan syndrome-causing genes: Molecular update and an assessment of the mutation rate.
    El Bouchikhi I; Belhassan K; Moufid FZ; Iraqui Houssaini M; Bouguenouch L; Samri I; Atmani S; Ouldim K
    Int J Pediatr Adolesc Med; 2016 Dec; 3(4):133-142. PubMed ID: 30805484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.
    Umeki I; Niihori T; Abe T; Kanno SI; Okamoto N; Mizuno S; Kurosawa K; Nagasaki K; Yoshida M; Ohashi H; Inoue SI; Matsubara Y; Fujiwara I; Kure S; Aoki Y
    Hum Genet; 2019 Jan; 138(1):21-35. PubMed ID: 30368668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Succesful MEK-inhibition of severe hypertrophic cardiomyopathy in RIT1-related Noonan Syndrome.
    Leegaard A; Gregersen PA; Nielsen TØ; Bjerre JV; Handrup MM
    Eur J Med Genet; 2022 Nov; 65(11):104630. PubMed ID: 36184070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation-a review of the literature.
    Nemcikova M; Vejvalkova S; Fencl F; Sukova M; Krepelova A
    Eur J Pediatr; 2016 Apr; 175(4):587-92. PubMed ID: 26518681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [RIT1: a novel gene associated with Noonan syndrome].
    Arroyo-Carrera I; Solo de Zaldivar-Tristancho M; Martin-Fernandez R; Vera-Torres M; Gonzalez de Buitrago-Amigo JF; Botet-Rodriguez J
    Rev Neurol; 2016 Oct; 63(8):358-362. PubMed ID: 27699752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
    Yagasaki H; Nakane T; Hasebe Y; Watanabe A; Kise H; Toda T; Koizumi K; Hoshiai M; Sugita K
    Am J Med Genet A; 2015 Dec; 167A(12):3144-7. PubMed ID: 26286251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.